Literature DB >> 10665263

The neuropsychiatry of stroke.

E Chemerinski1, R G Robinson.   

Abstract

Stroke represents a major public health problem in the United States, but relatively little work has been directed toward identifying and treating the common neuropsychiatric disorders occurring after stroke. This review discusses clinical and pathological correlates of depression, anxiety disorder, catastrophic reactions, pathological affect, or psychosis after stroke, as well as their epidemiology. Depressive disorder and anxiety disorder have been shown to inhibit physical recovery from stroke. It seems likely that other psychiatric disorders also inhibit recovery and limit quality of life. There are very few controlled trials examining the effectiveness of treatments for these disorders after stroke. Both depression and pathological affect, however, can be effectively treated with antidepressant medications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10665263     DOI: 10.1016/S0033-3182(00)71168-6

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  30 in total

Review 1.  The use of psychotropics in the medically ill.

Authors:  M J Robinson; J L Levenson
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 2.  Poststroke depression: a review.

Authors:  Robert G Robinson; Gianfranco Spalletta
Journal:  Can J Psychiatry       Date:  2010-06       Impact factor: 4.356

3.  Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression.

Authors:  Xuan Wang; Yue-Hua Li; Ming-Hua Li; Jing Lu; Jun-Gong Zhao; Xiao-Jiang Sun; Bin Zhang; Jian-Lin Ye
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-18       Impact factor: 5.270

Review 4.  Brain-mapping techniques for evaluating poststroke recovery and rehabilitation: a review.

Authors:  James C Eliassen; Erin L Boespflug; Martine Lamy; Jane Allendorfer; Wen-Jang Chu; Jerzy P Szaflarski
Journal:  Top Stroke Rehabil       Date:  2008 Sep-Oct       Impact factor: 2.119

5.  Effect of antidepressants on the course of disability following stroke.

Authors:  Katsunaka Mikami; Ricardo E Jorge; Harold P Adams; Patricia H Davis; Enrique C Leira; Mijin Jang; Robert G Robinson
Journal:  Am J Geriatr Psychiatry       Date:  2011-12       Impact factor: 4.105

6.  Clinically relevant depressive symptoms and peripheral arterial disease in elderly men and women. Results from a large cohort study in Southern China.

Authors:  Samuel Y S Wong; Jean Woo; Athena W L Hong; Jason C S Leung; Ping C Leung
Journal:  J Psychosom Res       Date:  2007-11       Impact factor: 3.006

7.  Neuropsychiatric manifestation after a stroke: newly developed symptoms or side-effect of drug?

Authors:  Eng Chai Tan; Noor Azah Aziz; Saharuddin Ahmad
Journal:  BMJ Case Rep       Date:  2012-08-18

8.  Use of milnacipran in patients suffering from poststroke depression.

Authors:  Harish Arora; Rajdeep Kaur
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

9.  Poststroke Neuropsychiatric Illness: An Integrated Approach to Diagnosis and Management.

Authors:  James A. Bourgeois; Donald M. Hilty; Celia H. Chang; Mark A. Wineinger; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

10.  Minimal depression: how does it relate to upper-extremity impairment and function in stroke?

Authors:  Lindy L Weaver; Stephen J Page; Lynne Sheffler; John Chae
Journal:  Am J Occup Ther       Date:  2013 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.